• Something wrong with this record ?

Predictive role BLVRA mRNA expression in hepatocellular cancer

KN. Kubícková, I. Subhanová, R. Konícková, L. Matousová, P. Urbánek, H. Parobková, M. Kupec, J. Pudil, L. Vítek,

. 2016 ; 15 (6) : 881-887.

Language English Country Mexico

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc17013482

Grant support
NT13092 MZ0 CEP Register

Introduction and aim. Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor. It is primarily caused by hepatic cirrhosis or chronic viral hepatitis. Hepatic carcinogenesis is associated with increased oxidative stress. Thus, the aim of our study was to assess expression of the genes involved in the homeostasis of oxidative stress in patients with HCC. MATERIAL AND METHODS: The study was performed on 32 patients with primary HCC (verified by liver histology in 29 patients) and 27 control subjects (in 11 subjects, liver histology was available either with no or minimal changes in the liver tissue). Gene expressions of heme oxygenase 1 (HMOX1), biliverdin reductase A/B (BLVRA/B), NADPH oxidase 2 (NOX2) and p22phox were analyzed in the liver and peripheral blood leukocytes (PBL) in the subjects. RESULTS: Compared to controls, almost a 3 times higher mRNA level of BLVRA was detected in livers of HCC patients (p = 0.002); while those of BLVRB as well as HMOX1 were unchanged (p > 0.05). In accord with these results in the liver tissue, BLVRA mRNA levels in PBL were also significantly increased in HCC patients (p = 0.012). mRNA levels of NOX2 and p22phox in the liver tissue, although higher in HCC patients, did not differ significantly compared to control subjects (p > 0.05). Nevertheless, NOX2 mRNA level in PBL was significantly higher in HCC patients (p = 0.003). CONCLUSIONS: BLVRA mRNA levels in the liver as well as in PBL are significantly higher in HCC patients most likely as a feedback mechanism to control increased oxidative stress associated with HCC progression.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013482
003      
CZ-PrNML
005      
20191031113625.0
007      
ta
008      
170413s2016 mx f 000 0|eng||
009      
AR
024    7_
$a 10.5604/16652681.1222104 $2 doi
035    __
$a (PubMed)27740521
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a mx
100    1_
$a Kubíčková, Kristýna $u Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague, and Military University Hospital, Prague, Czech Republic. $7 xx0269543
245    10
$a Predictive role BLVRA mRNA expression in hepatocellular cancer / $c KN. Kubícková, I. Subhanová, R. Konícková, L. Matousová, P. Urbánek, H. Parobková, M. Kupec, J. Pudil, L. Vítek,
520    9_
$a Introduction and aim. Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor. It is primarily caused by hepatic cirrhosis or chronic viral hepatitis. Hepatic carcinogenesis is associated with increased oxidative stress. Thus, the aim of our study was to assess expression of the genes involved in the homeostasis of oxidative stress in patients with HCC. MATERIAL AND METHODS: The study was performed on 32 patients with primary HCC (verified by liver histology in 29 patients) and 27 control subjects (in 11 subjects, liver histology was available either with no or minimal changes in the liver tissue). Gene expressions of heme oxygenase 1 (HMOX1), biliverdin reductase A/B (BLVRA/B), NADPH oxidase 2 (NOX2) and p22phox were analyzed in the liver and peripheral blood leukocytes (PBL) in the subjects. RESULTS: Compared to controls, almost a 3 times higher mRNA level of BLVRA was detected in livers of HCC patients (p = 0.002); while those of BLVRB as well as HMOX1 were unchanged (p > 0.05). In accord with these results in the liver tissue, BLVRA mRNA levels in PBL were also significantly increased in HCC patients (p = 0.012). mRNA levels of NOX2 and p22phox in the liver tissue, although higher in HCC patients, did not differ significantly compared to control subjects (p > 0.05). Nevertheless, NOX2 mRNA level in PBL was significantly higher in HCC patients (p = 0.003). CONCLUSIONS: BLVRA mRNA levels in the liver as well as in PBL are significantly higher in HCC patients most likely as a feedback mechanism to control increased oxidative stress associated with HCC progression.
650    _2
$a senioři $7 D000368
650    _2
$a nádorové biomarkery $x krev $x genetika $7 D014408
650    _2
$a hepatocelulární karcinom $x krev $x enzymologie $x genetika $x patologie $7 D006528
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a regulace genové exprese enzymů $7 D015971
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a hemoxygenasa-1 $x genetika $7 D051547
650    _2
$a lidé $7 D006801
650    _2
$a nádory jater $x krev $x enzymologie $x genetika $x patologie $7 D008113
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a membránové glykoproteiny $x genetika $7 D008562
650    _2
$a lidé středního věku $7 D008875
650    _2
$a NADPH-oxidasy $x genetika $7 D019255
650    _2
$a oxidační stres $x genetika $7 D018384
650    _2
$a oxidoreduktasy působící na CH-CH vazby $x krev $x genetika $7 D044925
650    _2
$a messenger RNA $x genetika $7 D012333
650    _2
$a signální transdukce $7 D015398
650    _2
$a upregulace $7 D015854
655    _2
$a časopisecké články $7 D016428
700    1_
$a Subhanová, Iva $u Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital, and 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. $7 xx0143799
700    1_
$a Konícková, Renáta $u Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital, and 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Matousová, Linda $u Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital, and 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Urbánek, Petr, $u Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague, and Military University Hospital, Prague, Czech Republic. $d 1969- $7 jn20001103565
700    1_
$a Parobková, Hana $u Department of Radiology, Military University Hospital, Prague, Czech Republic. $7 xx0241092
700    1_
$a Kupec, Martin $u Department of Oncology, 1st Faculty of Medicine, Charles University in Prague, and Thomayer Hospital, Prague, Czech Republic, Prague, Czech Republic. $7 xx0224786
700    1_
$a Pudil, Jiří $u Department of Surgery, 2nd Faculty of Medicine, Charles University in Prague, and Military University Hospital, Prague, Czech Republic. $7 xx0064618
700    1_
$a Vítek, Libor, $u Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital, and 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. $d 1969- $7 xx0035071
773    0_
$w MED00172549 $t Annals of hepatology $x 1665-2681 $g Roč. 15, č. 6 (2016), s. 881-887
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27740521 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20191031114106 $b ABA008
999    __
$a ok $b bmc $g 1199947 $s 974260
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 15 $c 6 $d 881-887 $i 1665-2681 $m Annals of hepatology $n Ann Hepatol $x MED00172549
GRA    __
$a NT13092 $p MZ0
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Archiving options